151 related articles for article (PubMed ID: 26011541)
1. Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping.
Alharbi NK; Chinnakannan SK; Gilbert SC; Draper SJ
PLoS One; 2015; 10(5):e0127978. PubMed ID: 26011541
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
[TBL] [Abstract][Full Text] [Related]
3. A Poxvirus Decapping Enzyme Colocalizes with Mitochondria To Regulate RNA Metabolism and Translation and Promote Viral Replication.
Cao S; Molina JA; Cantu F; Hernandez C; Yang Z
mBio; 2022 Jun; 13(3):e0030022. PubMed ID: 35435699
[TBL] [Abstract][Full Text] [Related]
4. Internal Ribosome Entry Site Dramatically Reduces Transgene Expression in Hematopoietic Cells in a Position-Dependent Manner.
Zheng Q; Zhang X; Yang H; Xie J; Xie Y; Chen J; Yu C; Zhong C
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597367
[TBL] [Abstract][Full Text] [Related]
5. Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
Baur K; Brinkmann K; Schweneker M; Pätzold J; Meisinger-Henschel C; Hermann J; Steigerwald R; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Sep; 84(17):8743-52. PubMed ID: 20538860
[TBL] [Abstract][Full Text] [Related]
6. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
Elroy-Stein O; Fuerst TR; Moss B
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6126-30. PubMed ID: 2548200
[TBL] [Abstract][Full Text] [Related]
7. Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene.
Lin AH; Liu Y; Burrascano C; Cunanan K; Logg CR; Robbins JM; Kasahara N; Gruber H; Ibañez C; Jolly DJ
Hum Gene Ther Methods; 2016 Apr; 27(2):59-70. PubMed ID: 26918465
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus D10 has broad decapping activity that is regulated by mRNA splicing.
Ly M; Burgess HM; Shah SB; Mohr I; Glaunsinger BA
PLoS Pathog; 2022 Feb; 18(2):e1010099. PubMed ID: 35202449
[TBL] [Abstract][Full Text] [Related]
9. A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.
Wennier ST; Brinkmann K; Steinhäußer C; Mayländer N; Mnich C; Wielert U; Dirmeier U; Hausmann J; Chaplin P; Steigerwald R
PLoS One; 2013; 8(8):e73511. PubMed ID: 23951355
[TBL] [Abstract][Full Text] [Related]
10. Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.
Hodge JW; Poole DJ; Aarts WM; Gómez Yafal A; Gritz L; Schlom J
Cancer Res; 2003 Nov; 63(22):7942-9. PubMed ID: 14633725
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression.
Parrish S; Resch W; Moss B
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2139-44. PubMed ID: 17283339
[TBL] [Abstract][Full Text] [Related]
12. Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
Orubu T; Alharbi NK; Lambe T; Gilbert SC; Cottingham MG
PLoS One; 2012; 7(6):e40167. PubMed ID: 22761956
[TBL] [Abstract][Full Text] [Related]
13. Differential bicistronic gene translation mediated by the internal ribosome entry site element of encephalomyocarditis virus.
Shen CR; Chen YS; Hwang YS; Chen HJ; Liu CL
Biomed J; 2021 Dec; 44(6 Suppl 1):S54-S62. PubMed ID: 35747995
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the EMCV IRES in plants.
Urwin P; Yi L; Martin H; Atkinson H; Gilmartin PM
Plant J; 2000 Dec; 24(5):583-9. PubMed ID: 11123797
[TBL] [Abstract][Full Text] [Related]
15. [Translational efficiency of BVDV IRES and EMCV IRES for T7 RNA polymerase driven cytoplasmic expression in mammalian cell lines].
Ghassemi F; Madadgar O; Roohvand F; Rasekhian M; Etemadzadeh MH; Boroujeni GRN; Langroudi AG; Azadmanesh K
Mol Biol (Mosk); 2017; 51(2):324-333. PubMed ID: 28537239
[TBL] [Abstract][Full Text] [Related]
16. Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme.
Soulière MF; Perreault JP; Bisaillon M
Nucleic Acids Res; 2010 Nov; 38(21):7599-610. PubMed ID: 20639534
[TBL] [Abstract][Full Text] [Related]
17. Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome.
Cottingham MG; Gilbert SC
J Virol Methods; 2010 Sep; 168(1-2):233-6. PubMed ID: 20417665
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses.
Parrish S; Moss B
J Virol; 2007 Dec; 81(23):12973-8. PubMed ID: 17881455
[TBL] [Abstract][Full Text] [Related]
19. Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter.
Alharbi NK; Spencer AJ; Salman AM; Tully CM; Chinnakannan SK; Lambe T; Yamaguchi Y; Morris SJ; Orubu T; Draper SJ; Hill AV; Gilbert SC
Vaccine; 2016 Jan; 34(1):49-55. PubMed ID: 26616553
[TBL] [Abstract][Full Text] [Related]
20. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
